Intra-Cellular Therapies Inc
NASDAQ:ITCI

Watchlist Manager
Intra-Cellular Therapies Inc Logo
Intra-Cellular Therapies Inc
NASDAQ:ITCI
Watchlist
Price: 131.81 USD 0.05% Market Closed
Market Cap: 14B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+289%
Revenue
Forecast
+18%
Operating Income
Forecast
+58%
Net Income
Forecast
N/A

Wall Street
Price Targets

ITCI Price Targets Summary
Intra-Cellular Therapies Inc

Wall Street analysts forecast ITCI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ITCI is 133.21 USD with a low forecast of 119.18 USD and a high forecast of 138.6 USD.

ITCI Lowest Forecast
Wall Street Target
119.18 USD
10% Downside
ITCI Average Forecast
Wall Street Target
133.21 USD
1% Upside
ITCI Highest Forecast
Wall Street Target
138.6 USD
5% Upside
Lowest
Price Target
119.18 USD
10% Downside
Average
Price Target
133.21 USD
1% Upside
Highest
Price Target
138.6 USD
5% Upside
Intra-Cellular Therapies Inc Competitors:
Price Targets
4151
Kyowa Kirin Co Ltd
31% Upside
SNT
Syntara Ltd
148% Upside
RX
Biosyent Inc
7% Upside
H
600566
Hubei Jumpcan Pharmaceutical Co Ltd
92% Upside
4151
Kyowa Kirin Co Ltd
31% Upside
SNT
Syntara Ltd
148% Upside
RX
Biosyent Inc
7% Upside
H
600566
Hubei Jumpcan Pharmaceutical Co Ltd
92% Upside
2096
Simcere Pharmaceutical Group Ltd
19% Upside

Revenue
Forecast

Revenue Estimate
Intra-Cellular Therapies Inc

For the last 8 years the compound annual growth rate for Intra-Cellular Therapies Inc's revenue is 163%. The projected CAGR for the next 3 years is 48%.

163%
Past Growth
48%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Intra-Cellular Therapies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Intra-Cellular Therapies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
What are analyst estimates?

See Also

Summary
ITCI intrinsic value, competitors valuation, and company profile.
DCF Valuation
ITCI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ITCI stock valuation using valuation multiples.
Wall Street Estimates
ITCI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ITCI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ITCI's stock price target?
Price Target
133.21 USD

According to Wall Street analysts, the average 1-year price target for ITCI is 133.21 USD with a low forecast of 119.18 USD and a high forecast of 138.6 USD.

What is Intra-Cellular Therapies Inc's Revenue forecast?
Projected CAGR
48%

For the last 8 years the compound annual growth rate for Intra-Cellular Therapies Inc's revenue is 163%. The projected CAGR for the next 3 years is 48%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 242,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.